This post was written by Angel Smith Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors. Amidst a race with its ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

Novo Nordisk (NVO) and Eli Lilly (LLY), the undisputed leaders in the global obesity drug market, saw their stocks heading in ...

Indianapolis-based Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors such alcohol abuse, smoking and drug ...

Eli Lilly (NYSE:LLY) is scheduled to announce Q3 ... LLY is up 55.6% so far this year and is rated as Hold according to SA ...